* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download International Symposium on One Health and INDOHUN Annual
Survey
Document related concepts
Sexually transmitted infection wikipedia , lookup
2015–16 Zika virus epidemic wikipedia , lookup
Leptospirosis wikipedia , lookup
Eradication of infectious diseases wikipedia , lookup
Hepatitis B wikipedia , lookup
Cross-species transmission wikipedia , lookup
Herpes simplex virus wikipedia , lookup
West Nile fever wikipedia , lookup
Swine influenza wikipedia , lookup
Orthohantavirus wikipedia , lookup
Ebola virus disease wikipedia , lookup
Antiviral drug wikipedia , lookup
Marburg virus disease wikipedia , lookup
Middle East respiratory syndrome wikipedia , lookup
Influenza A virus wikipedia , lookup
Transcript
International Symposium on One Health and INDOHUN Annual Meeting Perspective and Factors Contributing to Emerging and Re-emerging Pandemics Saul Tzipori, DVM, PhD, DSc, FRCVS Department of Infectious Disease and Global Health Solo, October 22, 2014 GLOBAL EXAMPLES OF EMERGING AND RE-EMERGING INFECTIOUS DISEASES AS Fauci Examples of Pathogens Emerged* or Recognized in humans for the first YEAR MICROBE DISEASE 1973 (1968) Rotavirus Major cause of infantile diarrhea globally 1976 (1907) Cryptosporidium hominis Acute and chronic diarrhea 1997* Ebola virus Ebola hemorrhagic fever ~1970 Enterovirus 71 (C) Hand, Foot, Mouth Disease (death from CNS) 1983* HIV AIDS 1984* E. Coli O157:H7 (enterohemorrhagic) Hemorrhagic colitis & HUS 1985 Enterocytozoon bieneusi (microsporidiosis) Chronic diarrhea and wasting in HIV/AIDS 1992* Vibrio cholerae O139 New strain associated with epidemic cholera 1994* Hendra virus Respiratory and CNS disease (horses/& humans) 1995* Human herpes virus-8 Associated with Kaposi sarcoma in AIDS patients 1997* Avian Influenza [Type A (H5N1)] Influenza 1999 Nipah virus Influenza-like symptoms (deaths from CNS) 2003* SARS coronavirus SARS - Severe Acute Respiratory Syndrome 2005* Clostridium difficile (highly virulent strains) Pseudomembranous colitis 2011* Swine influenza [H1N1] influenza 2012* MERS Middle East Respiratory Syndrome Emerging Infectious Diseases Newly Recognized Diseases Marburg Legionnaires' Disease Toxic Shock Syndrome Lyme Disease Campylobacteriosis Vibrio vulnificus Infections Helicobacter Infections (Ulcers) Bartonella Infections (Cat Scratch) Opportunistic Molds The Threat of Zoonotic Disease is Not New Beyond HIV/AIDS, SAR, MERS, Ebola, Avian flu, Nipah virus, etc Malaria - Plasmodium falciparum - Probably birds Malaria - Plasmodium vivax - Asian macaques Sleeping sickness - Trypanosoma brucei subsp.. - Wild ruminants Diphtheria - Corynebacterium diphtheriae - Domestic herbivores Hepatitis Hepatitis B virus - Apes Respiratory Infections Human coronavirus OC43 - Bovine Influenza Influenza A virus - Wildfowl Measles - virus - Sheep/goats Plague - Yersinia pestis - Rodents Dengue fever virus - Old World primates Yellow fever virus - African primates Smallpox - Variola virus - Ruminants (camels) Mumps virus - Mammals (pigs) (Source: Adapted from Wolfe et al. (2007) Some Profound Events in Infectious Diseases in Human History Bubonic Plague in 16th-17th Europe leading to reforms in sanitation. Smallpox was a major killer of young and the unimmunized leading to development of vaccination. Group A Streptococcal infection in 1840 initiated chlorinated lime solution in hand washing Spanish flu pandemic of Influenza in 1918 (HIN1), and the impact of globalization HIV/AIDS appeared in 1981 initiated a worldwide pandemic, and introduced massive anti retroviral therapy Factors Contributing to Emergence or Reemergence of zoonotic Infectious Diseases Microbial evolution Urbanization Large population migration Rapid long distance transportation of people and material Natural disasters (earth quakes, Tsunamis, floods) Intrusion into new uninhabited lands Climatic changes Decreased vaccination Increased number of Immunosuppressed individuals Increased antimicrobial resistance due to overuse Factor contributing to the spread of emerging new zoonotic diseases The origins of newly emerging diseases have been found to strongly correlate with specific: 1) Geographic areas, 2) Animal hosts, 3) Microbial agents, 4) High risk populations. Southeast Asia Cambodia China Indonesia Laos Malaysia Philippines Thailand Vietnam Amazon Bolivia Brazil Colombia Ecuador Mexico Peru Congo region Angola Burundi Cameroon CAR Congo DR Congo Eq. Guinea Gabon Rwanda Tanzania Uganda South Asia Bangladesh India Nepal Credit: USAID, EcoHealth Alliance The Rise of Zoonotic Diseases The emergence of the H5N1, SARS and H1N1, H9N7 and MERS viruses are examples of an accelerated dynamic pace that has given rise to a new and increasingly deadly zoonotic diseases. • Of these new zoonotic diseases, ¾ were caused by pathogens originating in wildlife •–SARS, emerged in Guangdong Province, China; •–Nipah virus in Perak State, Malaysia; and •–HIV in Central Africa. •--MERS in the middle East • Domestic animals are the other major source of zoonotic pathogens responsible for ~20% of all new zoonotic diseases. • RNA viruses e.g. highly pathogenic H5NI Influenza virus, because of their high rates of mutation and higher capacity to adapt to new hosts 2. Hot Animal Species Approx. 50,000 vertebrate species are potential reservoirs for viruses, bacteria, and others that could potentially infect humans. However, not all animal hosts are equal in their potential for ability to transfer microbial agents to humans because: Very few of these species will ever have direct or even indirect contact with people. W. Ian Lipkin (2009): Microbe Hunting in the 21st Century: PNAS:vol106(1 ) Hot Species: Rodents, Bats, Avian, and Primates Animal-to-human and animal-to-domestic animal interactions provide ideal setting for pathogens to evolve as humans pathogens The numbers of species for these transfers appear limited: Rodents - have proved highly adaptive in their ability to spread pathogens to humans - Hanta virus through their feces and urine; Bats - have infected people with Nipah virus directly through contaminated feces and indirectly by infecting pigs who are later consumed by humans. Primates - infected by bats with Ebola and Marburg viruses) have been the source of human infections when consumed as bush meat. Avian species – are responsible for the emergence of many avian Influenza strains) “High-Risk” Microbial Agents Targets for Surveillance (Predict) Target families of pathogens that have demonstrated capacity to “infect”, “spread”, and “kill”. Examples of families that are capable of acquiring human-to-human transmission, are therefore pose special risks to humans: RNA viruses, such as: retroviruses (HIV/AIDS), influenza A viruses, Coronaviruses (SARS, MERS), and Filoviruses (Ebola and Marburg) 4. Populations Targets for Surveillance People and populations with high levels of exposure (directly and indirectly) to wild animals: hunters, butchers of wild game, bush meat traders and consumers settlements abutting wildlife areas Farmers domestic animals loggers, miners, road builders etc. “Risk-Based” Surveillance - Conclusions The relationship between risky: 1. geographic “hot spots”; 2. animal hosts; 3. microbial agents; and 4. At-risk populations demonstrate that the emergence of new zoonotic diseases strongly correlates with: • socio-economic, • environmental, • genetic, • biological, and • ecological factors. You can do a lot of damage with just seven genes • Ebola is a simple and subtle virus. • The stringy virus consists of a genome wrapped up in two layers of proteins • This long thin string contains the polymerase, nucleoproteins and is studded with a glycoproteins (proteins with sugar stuck to them make them less immunogenic) • Inside the infected cell the polymerase makes massive copies of the genome You can do a lot of damage with just seven genes (The Economist Oct 18th 2014) • • • • • • Viral Pathogenesis The virus makes cells produce more glycoprotein than it needs. The surplus is secreted into the bloodstream. Antibodies which would otherwise attack the virus stick to this decoy protein instead. Immune cells carry the virus in the bloodstream to infect the liver, the spleen and lymph nodes. Symptoms may manifest from 1 to weeks. Eventually the virus triggers an s a cytokine storm. Blood-vessel walls become leaky, blood pressure and core temperature drop, organs fail and the body goes into shock. Various combinations of those and other symptoms kill about 70% of those who get ill Uniqueness of this outbreak Earlier outbreaks were often in isolated places with few opportunities for transmission of the virus between a wild animal and a human to set off such outbreaks. The west African outbreak has broken through the barriers of isolation and into the general population, both in the countryside and the cities, and it was up and running before public-health personnel fully realized the magnitude. There is no reason to expect it to subside of its own accord, nor to expect it to come under control in the absence of a far larger effort to stop it The Current Status • On Oct. 15th the WHO released its latest update. • The outbreak has now seen 8,997 confirmed, probable and suspected cases of Ebola. • All but 24 of those have been in Guinea (16% of the total), Sierra Leone (36%) and Liberia (47%). • The current death toll is 4,493. These numbers are underestimates; many cases, in some places probably most, go unreported. Emerging Diseases Hendra virus Nipah virus Nipah Virus Infection Human patient symptoms: “Flu-like” illness Fever Headache Vomiting Muscle pain Neurologic: dizziness, weakness, disorientation Severe: encephalitis, respiratory distress 545 cases, 316 deaths (58%) No cure – only supportive intensive care Nipah Beyond Malaysia 2001 - present Outbreaks in India and Bangladesh No swine involvement Humans consumed infected date palm sap Human to human transmission Emergence of SARS Severe Acute Respiratory Syndrome November 2002 Severe pneumonia-like illness in Guangdong China Not reported to World Health Organization Vague reports of a flu outbreak Global Spread of SARS February 2003 Business traveler dies of undiagnosed respiratory illness in Hanoi, Vietnam Within weeks SARS cases reported across Asia March 2003 First case appears in Canada Cases reported across the United States April 2003 China began reporting on SARS outbreak Epidemic through mid 2004 29 countries Nearly 8500 cases and 900 deaths worldwide (A) Genome structures of SARS-CoV and MERS-CoV. Coleman C M , and Frieman M B J. Virol. 2014;88:52095212 Unique Attributes that make control of Influenza difficult Mutate rapidly: This allows quick changes in surface antigens, the target of the immune system, resulting in antigenic changes/variation: Antigenic drift: The gradual occurrence of spontaneous point mutation (change in a single RNA base) Antigenic shift: rare but result in either the H (hemagglutination), or the N (neuraminidase) often resulting from interspecies transmission. E.g. avian H1N1 flu infecting humans (1918, 1997) leading to “bird flu”. Two avian flu viruses (H5N1; H7N9), have caused fatal disease in humans, but transmission from human to human (so far only from bird to human) has not occurred! Genetic reassortment: when two flu viruses from different animal species infect the same host/cell therein, mixing the 8 RNA segments of the two. The new hybrid virus now has proteins from two different sources which the immune system does not recognize. Çç√ç√ç Influenza From 2003-2013 (February) Indonesia has reported the greatest number of human cases of Avian Influenza (H5N1) (http://gamapserver.who.int/mapLibrary/Files/Maps/2003_AvianInfluenza_GlobalMap_01Feb13.png) 33 The Principle of One Health (OH) Hotspots are where there is: a) intensive livestock production; b) recent, rapid demographic changes; c) encroachment on wildlife habitat Human Environment Daszak P, A Call for “Smart Surveillance”: A Lesson Learned from H1N1. EcoHealth, September 16, 2009 Animal Emergence is a “Rare” Event While the risk of new zoonotic diseases is increasing, their emergences is a rare events occurring at unpredictable times and places. The biggest obstacles to early detection of these diseases is the lack of sufficient, sensitive surveillance capacity geared toward rapid and reliable detection of highly unusual pathogens